Hakutulokset - V. Leguy
- Näytetään 1 - 7 yhteensä 7 tuloksesta
-
1
Venous thromboembolic events during warm autoimmune hemolytic anemia Tekijä S. Audia, Benoit Bach, M. Samson, Daniela Lakomy, Jean‐Baptiste Bour, Bénédicte Burlet, Julien Guy, Laurence Duvillard, Marine Branger, V. Leguy‐Seguin, S. Berthier, Marc Michel, Bernard Bonnotte
Julkaistu 2018Artigo -
2
Etiologies and prognostic factors of leukocytoclastic vasculitis with skin involvement Tekijä Kévin Bouiller, S. Audia, H. Devilliers, Evelyne Collet, Marie Hélène Aubriot, V. Leguy‐Seguin, S. Berthier, Philippe Bonniaud, P. Chavanet, J.-F. Besancenot, P. Vabres, Laurent Martin, Maxime Samson, Bernard Bonnotte
Julkaistu 2016Artigo -
3
Immunologic effects of rituximab on the human spleen in immune thrombocytopenia Tekijä S. Audia, M. Samson, Julien Guy, Nona Janikashvili, Jennifer Fraszczak, Malika Trad, Marion Ciudad, V. Leguy, S. Berthier, Tony Petrella, Serge Aho, Laurent Martin, Marc Maynadié, B. Lorcerie, Patrick Rat, N. Cheynel, Emmanuel Katsanis, Nicolas Larmonier, Bernard Bonnotte
Julkaistu 2011Artigo -
4
Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patients Tekijä A Guilhem, Anne‐Emmanuelle Fargeton, Anne-Claire Simon, P. Duffau, Jean‐Robert Harlé, Christian Lavigne, Marie‐France Carette, O Blétry, P. Kaminsky, V. Leguy, Nathalie Lerolle, Dominique Roux, M. Lambert, Thierry Chinet, Delphine Bonnet, Sophie Dupuis‐Girod, Sophie Rivière
Julkaistu 2017Artigo -
5
Preferential splenic CD8+ T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia Tekijä S. Audia, M. Samson, Matthieu Mahévas, Christophe Ferrand, Malika Trad, Marion Ciudad, Alexandrine Gautheron, Famky Seaphanh, V. Leguy, S. Berthier, Bruno César Corrêa Salles, Laurent Martin, B. Lorcerie, Pablo Ortega‐Deballon, Olivier Facy, Denis Caillot, Agnès Soudry‐Faure, Marc Michel, Bertrand Godeau, Nicolas Larmonier, Philippe Saas, Nona Janikashvili, Bernard Bonnotte
Julkaistu 2013Artigo -
6
Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial Tekijä Sophie Dupuis‐Girod, Sophie Rivière, Christian Lavigne, Anne‐Emmanuelle Fargeton, Brigitte Gilbert‐Dussardier, Vincent Grobost, V. Leguy‐Seguin, Hélène Maillard, S. Mohamed, Évelyne Decullier, Adeline Roux, Lorraine Bernard, Jean‐Christophe Saurin, N. Saroul, Frédéric Faure, C. Cartier, Romain Altwegg, Laurent Laccourreye, F. Oberti, Marjolaine Beaudoin, C. Dhelens, Céline Desvignes, Nicolas Azzopardi, Gilles Paintaud, Ruben Hermann, Thierry Chinet
Julkaistu 2023Artigo -
7
Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia Tekijä S. Audia, Marzia Rossato, Kim Santegoets, Sanne Spijkers, Catharina G. K. Wichers, Cornelis P. J. Bekker, Andries C. Bloem, Louis Boon, T.W.H. Flinsenberg, Ewoud B. Compeer, Theo van den Broek, Olivier Facy, Pablo Ortega‐Deballon, S. Berthier, V. Leguy‐Seguin, Laurent Martin, Marion Ciudad, M. Samson, Malika Trad, B. Lorcerie, Nona Janikashvili, Philippe Saas, Bernard Bonnotte, Timothy R. D. J. Radstake
Julkaistu 2014Artigo
Työkalut:
Liittyvät aiheet
Medicine
Immunology
Internal medicine
Spleen
Antibody
Biology
Immune system
Immune thrombocytopenia
Surgery
Adverse effect
Bevacizumab
Biochemistry
Chemotherapy
Cytotoxic T cell
Gastroenterology
In vitro
Rituximab
Splenectomy
Telangiectasia
Alternative medicine
Anemia
Autoimmune hemolytic anemia
B cell
Biopsy
CD40
CD8
Clinical trial
Cohort
Confidence interval
Coronavirus disease 2019 (COVID-19)